Daniel C Cattran Selected Research

Daniel C Cattran Research Topics

Disease

24	Proteinuria 01/2021 - 03/2003
10	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2021 - 05/2003
8	IGA Glomerulonephritis (IGA Nephropathy) 10/2019 - 11/2006
7	Chronic Kidney Failure (Chronic Renal Failure) 01/2016 - 07/2003
4	Kidney Diseases (Kidney Disease) 01/2022 - 07/2011
3	Renal Insufficiency (Renal Failure) 01/2022 - 07/2008
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 01/2004
3	Lupus Nephritis 01/2019 - 04/2011
3	Nephrotic Syndrome (Syndrome, Nephrotic) 11/2016 - 09/2009
3	Diabetes Mellitus 01/2013 - 11/2004
2	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2022 - 04/2012
2	Chronic Renal Insufficiency 01/2021 - 01/2016
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 08/2020 - 03/2003
2	Disease Progression 01/2019 - 07/2011
2	Vasculitis (Vasculitides) 05/2014 - 06/2011
2	Glomerulonephritis 10/2010 - 01/2004
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Pain (Aches) 08/2020
1	Body Weight (Weight, Body) 01/2019
1	Nephritis 01/2019
1	Paraproteinemias (Monoclonal Gammopathy) 01/2019
1	Fibrosis (Cirrhosis) 03/2016
1	Atrophy 03/2016
1	Hypoalbuminemia 06/2014
1	Hemorrhage 06/2014
1	Cryoglobulinemia 04/2012
1	Neoplasms (Cancer) 01/2012
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2011
1	Chronic Disease (Chronic Diseases) 04/2011
1	Dyslipidemias (Dyslipidemia) 04/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2005
1	Coronary Disease (Coronary Heart Disease) 10/2005
1	Insulin Resistance 11/2004
1	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 02/2004
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2004
1	Diabetes Complications 01/2004
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2004
1	Hypertension (High Blood Pressure) 04/2003

Drug/Important Bio-Agent (IBA)

10	CreatinineIBA 01/2019 - 05/2003
7	Rituximab (Mabthera)FDA Link 10/2019 - 12/2010
6	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2019 - 03/2003
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2019 - 06/2011
4	Proteins (Proteins, Gene)FDA Link 11/2016 - 09/2009
3	Serum AlbuminIBA 08/2020 - 01/2012
3	Angiotensin IIIBA 01/2015 - 04/2003
2	Pharmaceutical PreparationsIBA 01/2021 - 03/2003
2	Messenger RNA (mRNA)IBA 03/2016 - 10/2010
2	AlbuminsIBA 06/2014 - 10/2010
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Complement C3 (C3 Complement)IBA 01/2022
1	DiamondIBA 01/2021
1	dapagliflozinIBA 01/2021
1	SymportersIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	SodiumIBA 01/2021
1	AntibodiesIBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2019
1	AngiotensinsIBA 01/2019
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2016
1	ElementsIBA 12/2015
1	Monoclonal AntibodiesIBA 01/2015
1	coenzyme Q10 (CoQ10)IBA 12/2013
1	Immunoglobulin A (IgA)IBA 11/2013
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2013
1	Phospholipases (Phospholipase)IBA 08/2011
1	AutoantibodiesIBA 08/2011
1	Indicators and Reagents (Reagents)IBA 07/2011
1	Immunosuppressive Agents (Immunosuppressants)IBA 05/2010
1	Vitamin B Complex (B Vitamins)IBA 04/2010
1	VitaminsIBA 04/2010
1	Antihypertensive Agents (Antihypertensives)IBA 07/2008
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 06/2007
1	Valsartan (Vals)FDA Link 11/2006
1	CholesterolIBA 10/2006
1	EnzymesIBA 10/2005
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2004
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 11/2004
1	Oxidoreductases (Dehydrogenase)IBA 11/2004
1	Advanced Glycation End ProductsIBA 01/2004
1	pimagedine (aminoguanidine)IBA 01/2004
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 05/2003
1	Type 1 Angiotensin ReceptorIBA 04/2003
1	SteroidsIBA 03/2003

Therapy/Procedure

10	Therapeutics 08/2020 - 03/2003
3	Kidney Transplantation 01/2013 - 02/2004
2	Transplantation 11/2013 - 04/2011
1	Glycemic Control 01/2016
1	Immunotherapy 04/2011
1	Conservative Treatment 09/2009